Simvastatin and biphasic calcium phosphate affects bone formation in critical-sized rat calvarial defects

Acta Cir Bras. 2016 May;31(5):300-7. doi: 10.1590/S0102-865020160050000002.

Abstract

Purpose: To investigate the effects of locally applied simvastatin plus biphasic calcium phosphate (BoneCeramic(r)) or collagen sponge on bone formation in critical-sized bone defects.

Methods: Thirty defects of 5mm in diameter were created bilaterally with a trephine bur in the calvariae of fifteen Wistar rats. The defects were divided into five groups: group 1 - control, no treatment; group 2 (BoneCeramic(r)); group 3 (BoneCeramic(r) + 0.1mg simvastatin); group 4 (collagen sponge); and group 5 (collagen sponge + 0.1mg simvastatin). After eight weeks the animals were euthanized and their calvariae were histologically processed. Hematoxylin and eosin-stained sections were subjected to histological and histomorphometrical analyses. The area of newly formed bone was calculated and compared between groups.

Results: The greater amount of a bone-like tissue was formed around the carrier in group 3 (BoneCeramic(r) + 0.1mg simvastatin) followed by group 2 (BoneCeramic(r)), and almost no bone was formed in the other groups. Group 3 was significantly different compared to group 2, and both groups were significantly different compared to the other groups.

Conclusion: Simvastatin combined with BoneCeramic(r) induced significantly greater amounts of newly formed bone and has great potential for the healing of bone defects.

MeSH terms

  • Animals
  • Anticholesteremic Agents / pharmacology*
  • Bone Matrix / ultrastructure
  • Collagen / drug effects
  • Disease Models, Animal
  • Female
  • Hydroxyapatites / pharmacology*
  • Osteogenesis / drug effects*
  • Rats, Wistar
  • Simvastatin / pharmacology*
  • Skull / drug effects*
  • Skull / injuries
  • Skull / pathology
  • Wound Healing

Substances

  • Anticholesteremic Agents
  • BoneCeramic
  • Hydroxyapatites
  • hydroxyapatite-beta tricalcium phosphate
  • Collagen
  • Simvastatin